Type 2 diabetes drugs may increase risk of pancreatic cancer

August 12, 2013 - A commonly prescribed class of Type 2 diabetes drugs known as incretin mimetics may put users at risk for developing pancreatic cancer, according to new research published in the British... Read More

Januvia, Byetta

June 10, 2013 - The FDA has issued several warnings about links between Byetta and Januvia to complications related to pancreatic diseases. Read More

back to top